ALLAKOS INC's ticker is ALLK and the CUSIP is 01671P100. A total of 118 filers reported holding ALLAKOS INC in Q3 2023. The put-call ratio across all filers is 0.75 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $189 | -92.5% | 83,310 | -85.7% | 0.00% | -90.0% |
Q2 2023 | $2,532 | +161.3% | 581,100 | +166.3% | 0.01% | +150.0% |
Q1 2023 | $969 | -81.6% | 218,175 | -65.1% | 0.00% | -84.6% |
Q4 2022 | $5,259 | -99.9% | 624,840 | -40.7% | 0.03% | -25.7% |
Q3 2022 | $6,443,000 | +73.5% | 1,052,845 | -11.2% | 0.04% | +84.2% |
Q2 2022 | $3,713,000 | +163.3% | 1,186,213 | +379.2% | 0.02% | +216.7% |
Q1 2022 | $1,410,000 | – | 247,543 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RiverVest Venture Management LLC | 4,887,932 | $29,914,000 | 34.73% |
Logos Global Management LP | 5,936,666 | $36,332,000 | 4.47% |
TCG Crossover Management, LLC | 1,643,500 | $10,058,000 | 3.02% |
Vivo Capital, LLC | 4,120,134 | $25,215,000 | 2.78% |
Ally Bridge Group (NY) LLC | 598,172 | $3,661,000 | 2.42% |
Frazier Life Sciences Management, L.P. | 4,792,000 | $29,327,000 | 2.26% |
NEA Management Company, LLC | 6,148,704 | $33,867,000 | 1.69% |
COMMODORE CAPITAL LP | 1,643,500 | $10,058,000 | 1.62% |
BVF INC/IL | 5,006,921 | $30,642,000 | 1.27% |
Deep Track Capital, LP | 4,518,575 | $27,654,000 | 1.27% |